Feb 29, 2024 / 01:30PM GMT
Operator
And then yes, good morning, ladies and gentlemen, and welcome to the Veeco Pharmaceuticals Fourth Quarter and Year-end 2023 Corporate Update and Earnings Conference Call. As a reminder, this conference is being recorded. I'll now turn the call over to our host, Kevin Gordon of LifeSci Advisors. You may begin your conference.
Kevin Gardner - LifeSci Advisors LLC - Investor Relation
Thank you, operator. Hello, everyone, and welcome to Veritiv Pharmaceuticals Fourth Quarter and Year End 2023 Corporate Update and Earnings Conference Call. With me on the line this morning are Ted White, President and Chief Executive Officer of America pharmaceuticals, go Bonner CorSo, Chief Commercial Officer, Carrie Koehler, Chief Financial Officer, Dr. Gary Goldberg, Americas, Chief Medical Officer, and Chris Hayes, Americas team, Legal Officer.
As a reminder, during today's call, management will make forward looking statements. These statements may include expectations related to the launch and commercialization of Whitecap for the treatment of Luscombe can TGO., some in
Q4 2023 Verrica Pharmaceuticals Inc Earnings Call Transcript
Mar 01, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers